FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel compounds of formula: or its pharmaceutically acceptable salts, where Y represents COOR2; A represents -(CH2)6-, cys-CH2CH=CH-(CH2)3-, where 1 carbon atom can be substituted with O; or A represents -(CH2)m-Ar-(CH2)0-, where Ar represents phenylene or 5-member heteroarylene, which contains one heteroatom selected from O or S, sum of m and o constitutes from 1 to 4, and where one of groups CH2 can be substituted with O; and B represents phenyl, which can be substituted with C1-12 alkyl, hydroxy C1-12 alkyl; R2 represents H, C1-6 alkyl.
EFFECT: obtaining compounds for ophthalmological composition.
15 cl, 1 tbl, 16 dwg, 43 ex
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC SUBSTITUTED LACTAMS | 2008 |
|
RU2481342C9 |
NOVEL AMIDE DERIVATIVES OF PIPERIDINE CARBOXYLIC ACID | 2006 |
|
RU2410374C2 |
THERAPEUTIC COMPOUNDS | 2009 |
|
RU2500674C2 |
HETEROCYCLIC COMPOUNDS AS CRTH2 RECEPTOR ANTAGONISTS | 2008 |
|
RU2451019C2 |
HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES | 2007 |
|
RU2479575C2 |
2-PYRIDYL SUBSTITUTED IMIDAZOLES AS ALK5 AND/OR ALK4 INHIBITORS | 2012 |
|
RU2612958C2 |
SECONDARY AMINES AS RENIN INHIBITORS | 2007 |
|
RU2425032C2 |
SUBSTITUTED CYCLOPENTANS POSSESSING PROSTAGLANDIN ACTIVITY | 2008 |
|
RU2481339C2 |
4-IMIDAZOLINES AS TAAR LIGANDS | 2007 |
|
RU2465269C2 |
SULFONAMIDE PERI-SUBSTITUTED BICYCLES FOR TREATMENT OF OCCLUSIVE AFFECTION OF ARTERIES | 2005 |
|
RU2403240C2 |
Authors
Dates
2011-02-27—Published
2006-03-06—Filed